Madrigal Pharmaceuticals (MIL:1MDGL) FCF Margin %: -55.02% (As of Mar. 2026)

What is Madrigal Pharmaceuticals FCF Margin %?

Madrigal Pharmaceuticals MIL:1MDGL 8 FCF Margin % is -55.02% as of Mar. 2026. GuruFocus rates MIL:1MDGL with a GF Score™ of 8/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Madrigal Pharmaceuticals ranks better than 62.04% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Madrigal Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was €-148.2 Mil. Madrigal Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was €269.3 Mil. Therefore, Madrigal Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was -55.02%.

As of today, Madrigal Pharmaceuticals's current FCF Yield % is -2.30%.

The historical rank and industry rank for Madrigal Pharmaceuticals's FCF Margin % or its related term are showing as below:

MIL:1MDGL' s FCF Margin % Range Over the Past 10 Years
Min: -256.5 Med: -138.32 Max: -20.14
Current: -24.15

During the past 13 years, the highest FCF Margin % of Madrigal Pharmaceuticals was -20.14%. The lowest was -256.50%. And the median was -138.32%.

MIL:1MDGL's FCF Margin % is ranked better than
62.04% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs MIL:1MDGL: -24.15

Madrigal Pharmaceuticals FCF Margin % Related Terms

Madrigal Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Madrigal Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Madrigal Pharmaceuticals FCF Margin % Chart

Madrigal Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

0.00

-256.50

-20.14

Madrigal Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-64.77	-22.11	27.80	-41.57	-55.02

MIL:1MDGL vs BMRN, ARWR, AXSM: FCF Margin % Comparison

For the Biotechnology subindustry, Madrigal Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Madrigal Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Madrigal Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Madrigal Pharmaceuticals's FCF Margin % falls into.

Save Embed

8GF Score

Madrigal Pharmaceuticals Inc MIL:1MDGL

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Madrigal Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Madrigal Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-164.839	/	818.476
	=	-20.14 %

Madrigal Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-148.16	/	269.307
	=	-55.02 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -55.02% mean?

Madrigal Pharmaceuticals (MIL:1MDGL) has a FCF Margin % of -55.02% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Madrigal Pharmaceuticals and its competitors. According to the industry distribution chart, Madrigal Pharmaceuticals ranks #364 out of 959 companies in the Biotechnology industry, placing it in the top 38%.

Is Madrigal Pharmaceuticals' FCF Margin % too high?

Madrigal Pharmaceuticals' current FCF Margin % is -55.02%. Based on the distribution chart, Madrigal Pharmaceuticals ranks #364 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Madrigal Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.

How does Madrigal Pharmaceuticals' FCF Margin % compare to BMRN and ARWR?

According to the Biotechnology industry distribution chart, Madrigal Pharmaceuticals ranks #364 out of 959 companies for FCF Margin %. This puts Madrigal Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Madrigal Pharmaceuticals and its competitors. Madrigal Pharmaceuticals's current FCF Margin % is -55.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Madrigal Pharmaceuticals stock overvalued right now?

Madrigal Pharmaceuticals (MIL:1MDGL) has a current FCF Margin % of -55.02%. The current FCF Margin % is -55.02%. Madrigal Pharmaceuticals' overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Madrigal Pharmaceuticals (MIL:1MDGL), the current FCF Margin % is -55.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Madrigal Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies BMRN ARWR AXSM CYTK IONS EXEL BBIO PRAX SMMT KRYS VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges MDGL:USA 0JXI:UK YDO1:Germany

Address 200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428

Website https://www.madrigalpharma.com

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

8GF Score

Get the complete analysis for MIL:1MDGL

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€416.00

Price

View MIL:1MDGL Analysis

See FCF Margin % data for all stocks →